Goos M - Search Results

1

EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Peréz JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ. Willemze R, et al. Among authors: goos m. Blood. 1997 Jul 1;90(1):354-71. Blood. 1997. PMID: 9207472 Free article. Review.

2

[In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].

Sterry W, Steigleder GK, Goos M, Meisterernst E. Sterry W, et al. Among authors: goos m. Z Hautkr. 1982 Apr 15;57(8):567-76. Z Hautkr. 1982. PMID: 6124066 German.

3

In situ identification and enumeration of helper T lymphocytes in cutaneous malignant lymphomas by dipeptidyl-peptidase IV (DPP IV).

Sterry W, Steigleder GK, Goos M, Meisterernst E. Sterry W, et al. Among authors: goos m. J Cutan Pathol. 1982 Apr;9(2):119-20. doi: 10.1111/j.1600-0560.1982.tb01049.x. J Cutan Pathol. 1982. PMID: 7047598 No abstract available.

4

A family study of atopic dermatitis. Clinical and genetic characteristics of 188 patients and 2,151 family members.

Küster W, Petersen M, Christophers E, Goos M, Sterry W. Küster W, et al. Among authors: goos m. Arch Dermatol Res. 1990;282(2):98-102. doi: 10.1007/BF00493466. Arch Dermatol Res. 1990. PMID: 2353830

5

C-KIT expression in primary cutaneous T-cell lymphomas.

Brauns TC, Schultewolter T, Dissemond J, Maschke J, Goos M. Brauns TC, et al. Among authors: goos m. J Cutan Pathol. 2004 Oct;31(9):577-82. doi: 10.1111/j.0303-6987.2004.00182.x. J Cutan Pathol. 2004. PMID: 15330987

6

Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.

Wagner SN, Wagner C, Reinhold U, Funk R, Zöller M, Goos M. Wagner SN, et al. Among authors: goos m. J Invest Dermatol. 1998 Sep;111(3):464-71. doi: 10.1046/j.1523-1747.1998.00302.x. J Invest Dermatol. 1998. PMID: 9740242 Free article. Clinical Trial.

7

Phenotypic heterogeneity of leukemic Sézary cells.

Feller AC, Ziegler A, Sterry W, Goos M, Parwaresch MR. Feller AC, et al. Among authors: goos m. Blut. 1983 Dec;47(6):333-41. doi: 10.1007/BF00320347. Blut. 1983. PMID: 6606455

8

Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.

Wagner SN, Ockenfels HM, Wagner C, Soyer HP, Goos M. Wagner SN, et al. Among authors: goos m. J Invest Dermatol. 1996 Feb;106(2):321-6. doi: 10.1111/1523-1747.ep12342979. J Invest Dermatol. 1996. PMID: 8601735 Free article.

9

Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.

Wagner SN, Schultewolter T, Wagner C, Briedigkeit L, Becker JC, Kwasnicka HM, Goos M. Wagner SN, et al. Among authors: goos m. Lab Invest. 1998 May;78(5):541-50. Lab Invest. 1998. PMID: 9605179

10

Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression.

Dissemond J, Götte P, Mörs J, Lindeke A, Goos M, Ferrone S, Wagner SN. Dissemond J, et al. Among authors: goos m. Melanoma Res. 2003 Jun;13(3):253-8. doi: 10.1097/00008390-200306000-00005. Melanoma Res. 2003. PMID: 12777979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page